Literature DB >> 9519757

Identification and functional analysis of sulfonylurea receptor 1 variants in Japanese patients with NIDDM.

Y Ohta1, Y Tanizawa, H Inoue, T Hosaka, K Ueda, A Matsutani, V P Repunte, M Yamada, Y Kurachi, J Bryan, L Aguilar-Bryan, M A Permutt, Y Oka.   

Abstract

The sulfonylurea receptor 1 (SUR1) is an essential regulatory subunit of the beta-cell ATP-sensitive K+ channel (K[ATP]). The possible role of SUR1 gene mutation(s) in the development of NIDDM remains controversial as both a positive association and negative linkage results have been reported. Therefore, we examined the SUR1 gene at the single nucleotide level with single strand conformation polymorphism analysis in 100 Japanese NIDDM patients. We identified a total of five amino acid substitutions and 17 silent mutations by examining all 39 exons of this gene. Two rare novel mutations, D811N in exon 20 and R835C in exon 21, were identified in the first nucleotide-binding fold (NBF), a functionally important region of SUR1, in one patient each, both heterozygotes. To analyze possible functional alterations, we reconstituted the mutant K(ATP) by coexpressing beta-cell inward rectifier (BIR) (Kir 6.2), a channel subunit of K(ATP), and mutant SUR1 in HEK293T and COS-7 cells. As demonstrated by the patch clamp technique and rubidium (Rb+) efflux studies, neither mutation alters the properties of channel activities. Two other rare missense mutations, R275Q in exon 6 and V560M in exon 12, were also identified. The R275Q substitution was not found in 67 control subjects, and V560M was present in three control subjects. Neither of these substitutions appeared to cosegregate with NIDDM in the probands' families. A previously reported S1370A substitution located in the second NBF was also common in the Japanese subjects (allelic frequency 0.37), and was found at an equal frequency in nondiabetic control subjects. In conclusion, SUR1 mutations impairing K(ATP) function do not appear to be major determinants of NIDDM susceptibility in Japanese.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9519757     DOI: 10.2337/diabetes.47.3.476

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  4 in total

1.  Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans.

Authors:  R Duggirala; J Blangero; L Almasy; T D Dyer; K L Williams; R J Leach; P O'Connell; M P Stern
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

2.  COL4A3 Gene Variants and Diabetic Kidney Disease in MODY.

Authors:  Yiting Wang; Junlin Zhang; Yingwang Zhao; Shanshan Wang; Jie Zhang; Qianqian Han; Rui Zhang; Ruikun Guo; Hanyu Li; Li Li; Tingli Wang; Xi Tang; Changzheng He; Geer Teng; Weiyue Gu; Fang Liu
Journal:  Clin J Am Soc Nephrol       Date:  2018-07-16       Impact factor: 8.237

3.  Replication of KCNJ11 (p.E23K) and ABCC8 (p.S1369A) Association in Russian Diabetes Mellitus 2 Type Cohort and Meta-Analysis.

Authors:  Ekaterina Alekseevna Sokolova; Irina Arkadievna Bondar; Olesya Yurievna Shabelnikova; Olga Vladimirovna Pyankova; Maxim Leonidovich Filipenko
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

4.  Ser1369Ala variant in sulfonylurea receptor gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients.

Authors:  Yan Feng; Guangyun Mao; Xiaowei Ren; Houxun Xing; Genfu Tang; Qiang Li; Xueqi Li; Lirong Sun; Jinqui Yang; Weiqing Ma; Xiaobin Wang; Xiping Xu
Journal:  Diabetes Care       Date:  2008-07-03       Impact factor: 17.152

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.